Evolution of covered stents in the contemporary era: clinical application,materials and manufacturing strategies using nanotechnology |
| |
Authors: | Yasmin Farhatnia Aaron Tan Aamir Motiwala Brian G. Cousins Alexander M. Seifalian |
| |
Affiliation: | 1. Centre for Nanotechnology and Regenerative Medicine, UCL Division of Surgery & Interventional Science, University College London, London, United Kingdom;2. UCL Medical School, University College London, London, United Kingdom;3. Royal Free London NHS Foundation Trust, London, United Kingdom |
| |
Abstract: | Endovascular stents have revolutionised the field of interventional cardiology. Despite their excellent clinical outcome complications associated with percutaneous stent implantation following the procedure have remained a major drawback in their widespread use. To overcome such limitations, a number of novel endovascular stents have emerged including a covered stent wrapped in a thin membrane sleeve. As well as prevention of complications associated with stenting, covered stents owing to their physical barrier are used as the treatment option of choice for trauma devices during emergency situations and to treat a number of pathological disease states. The aim of this review is to provide the reader with an overall objective outlook in the use of covered stents as a treatment option in a number of vascular complications and addresses their design and materials used in the manufacturing process. In addition, new strategies are highlighted and future prospects with the emergence of novel smart alloys for 3D scaffolds and the use of nanotechnology in the development of nanocomposite materials. |
| |
Keywords: | ADP, Adenosine diphosphate ATRP, Atom transfer radical polymerisation BMS, Bare metal stent(s) BSE, Bovine spongiform encephalopathy CABG, Coronary artery bypass graft surgery CAF, Coronary artery fistula CCF, Carotid cavernous fistulae CoA, Coarctation of the aorta CoCr, Cobalt chromium CP, Cheatham-platinum CPPs, Caseinophosphopeptides CVD, Chemical vapour deposition DES, Drug eluting stent(s) ECM, Extracellular matrix EPCs, Endothelial progenitor cells eNOS, Endothelial nitric oxide synthase HA, Hyaluronic acid ICA, Internal carotid artery IH, Intimal hyperplasia ISR, In-stent restenosis LAST, Late stent thrombosis MACE, Major adverse cardiac events MI, Myocardial infarctions PEG, Poly (ethylene glycol) PEO, Polyethylene oxide PET, Polyethylene terephthalate PLD, Pulsed laser deposition PLGA, Poly (lactic-co-glycolic acid) POSS, Polyhedral oligomeric silsesquioxane PTA, Percutaneous transluminal angioplasty PtCr, Platinum chromium PTFE, Polytetrafluoroethylene PU, Polyurethane RGD, Arginine&ndash glycine&ndash aspartic acid SC, Collagen film from salmon SMCs, Smooth muscle cells SNP, Sodium nitroprusside SVGs, Saphenous vein grafts TF, Tissue factor VEGFR, Vascular endothelial growth factor receptor VLST, Very late stage thrombosis vSMC, Vascular smooth muscle cells vWF, Von Willebrand factor WBCs, White blood cells |
本文献已被 ScienceDirect 等数据库收录! |
|